Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Benjamin H. Durham(Memorial Sloan Kettering Cancer Center), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center)
Cited by 226
Related Papers
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
|Cancer Discovery|2022|36
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
|Nature Cancer|2023|21
Mutant <i>PIK3CA</i> is a targetable driver alteration in histiocytic neoplasms
|Blood Advances|2023|10